These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 18514387)

  • 1. Editorial comment on: Intravesical botulinum toxin A administration inhibits COX-2 and EP4 expression and suppresses bladder hyperactivity in cyclophosphamide-induced cystitis in rats.
    Vignozzi L; Morelli A
    Eur Urol; 2009 Jul; 56(1):166. PubMed ID: 18514385
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravesical botulinum toxin A administration inhibits COX-2 and EP4 expression and suppresses bladder hyperactivity in cyclophosphamide-induced cystitis in rats.
    Chuang YC; Yoshimura N; Huang CC; Wu M; Chiang PH; Chancellor MB
    Eur Urol; 2009 Jul; 56(1):159-66. PubMed ID: 18514386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial comment on: histological changes in the urothelium and suburothelium of human overactive bladder following intradetrusor injections of botulinum neurotoxin type A for the treatment of neurogenic or idiopathic detrusor overactivity.
    Haferkamp A
    Eur Urol; 2008 Jun; 53(6):1253. PubMed ID: 18343561
    [No Abstract]   [Full Text] [Related]  

  • 4. Animal models of overactive bladder: cyclophosphamide (CYP)-induced cystitis in rats.
    Juszczak K; Królczyk G; Filipek M; Dobrowolski ZF; Thor PJ
    Folia Med Cracov; 2007; 48(1-4):113-23. PubMed ID: 19051698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced ATP release from rat bladder urothelium during chronic bladder inflammation: effect of botulinum toxin A.
    Smith CP; Vemulakonda VM; Kiss S; Boone TB; Somogyi GT
    Neurochem Int; 2005 Sep; 47(4):291-7. PubMed ID: 15970360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editorial comment on: Intravesical botulinum toxin A administration inhibits COX-2 and EP4 expression and suppresses bladder hyperactivity in cyclophosphamide-induced cystitis in rats.
    Giannantoni A
    Eur Urol; 2009 Jul; 56(1):166-7. PubMed ID: 18514387
    [No Abstract]   [Full Text] [Related]  

  • 7. The case for bladder botulinum toxin application.
    Kim DK; Thomas CA; Smith C; Chancellor MB
    Urol Clin North Am; 2006 Nov; 33(4):503-10, ix. PubMed ID: 17011386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applications of Botulinum toxin in urogynaecology.
    Sinha D; Karri K; Arunkalaivanan AS
    Eur J Obstet Gynecol Reprod Biol; 2007 Jul; 133(1):4-11. PubMed ID: 17275980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health economics and intradetrusor injections of botulinum for the treatment of detrusor overactivity.
    Sangster P; Kalsi V
    BJU Int; 2008 Jul; 102 Suppl 1():17-9. PubMed ID: 18665974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of action of intravesical botulinum treatment in refractory detrusor overactivity.
    Drake MJ
    BJU Int; 2008 Jul; 102 Suppl 1():11-6. PubMed ID: 18665973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia.
    Antunes AA; Srougi M; Coelho RF; de Campos Freire G
    Nat Clin Pract Urol; 2007 Mar; 4(3):155-60. PubMed ID: 17347660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resiniferatoxin and botulinum toxin type A for treatment of lower urinary tract symptoms.
    Cruz F; Dinis P
    Neurourol Urodyn; 2007 Oct; 26(6 Suppl):920-7. PubMed ID: 17705161
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.